Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.
competitor of
Metrics
marketSTOCKS
msh_idCOM:NEWBURYPHARMA
localese
websitehttps://www.newburypharma.com/
ipo_date2022-02-04
primary_stock_msh_idSTO:NEWBRY
source_ref97afc880-6dcf-44d1-adfc-4d82a2e3d2b3
products_or_servicesSpecialty prescription drugs, proprietary and licensed pharmaceuticals in oncology, rare diseases, and neurology.
Sweden